147 related articles for article (PubMed ID: 27237100)
21. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.
Myung SJ; Kim MH; Kim YS; Kim HJ; Park ET; Yoo KS; Lim BC; Wan Seo D; Lee SK; Min YI; Kim JY
Gastrointest Endosc; 2000 Jun; 51(6):708-13. PubMed ID: 10840305
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic accuracy of K-ras mutation for pancreatic carcinoma: a meta-analysis.
Liu SL; Chen G; Zhao YP; Wu WM; Zhang TP
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):458-64. PubMed ID: 24103274
[TBL] [Abstract][Full Text] [Related]
23. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
[TBL] [Abstract][Full Text] [Related]
24. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis.
Watanabe H; Sawabu N; Songür Y; Yamaguchi Y; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Wakabayashi T
Pancreas; 1996 Jan; 12(1):18-24. PubMed ID: 8927616
[TBL] [Abstract][Full Text] [Related]
25. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers.
Watanabe H; Sawabu N; Ohta H; Satomura Y; Yamakawa O; Motoo Y; Okai T; Takahashi H; Wakabayashi T
Jpn J Cancer Res; 1993 Sep; 84(9):961-5. PubMed ID: 8407563
[TBL] [Abstract][Full Text] [Related]
26. Detection of K-ras point mutation at codon 12 in pure pancreatic juice collected 3 years and 6 months before the clinical diagnosis of pancreatic cancer.
Wakabayashi T; Sawabu N; Watanabe H; Morimoto H; Sugioka G; Takita Y
Am J Gastroenterol; 1996 Sep; 91(9):1848-51. PubMed ID: 8792713
[TBL] [Abstract][Full Text] [Related]
27. Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial.
Trümper L; Menges M; Daus H; Köhler D; Reinhard JO; Sackmann M; Moser C; Sek A; Jacobs G; Zeitz M; Pfreundschuh M
J Clin Oncol; 2002 Nov; 20(21):4331-7. PubMed ID: 12409332
[TBL] [Abstract][Full Text] [Related]
28. Does detection of K-ras mutations in pancreatic juice influence clinical decision making?
O'Mahony S; Sreedharan A
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1141-2. PubMed ID: 11711767
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of chronic pancreatitis patients with K-ras mutation in the pancreatic juice.
Kamisawa T; Takuma K; Tabata T; Egawa N; Yamaguchi T
Hepatogastroenterology; 2011; 58(105):174-6. PubMed ID: 21510309
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis.
Tao LY; Zhang LF; Xiu DR; Yuan CH; Ma ZL; Jiang B
World J Surg Oncol; 2016 May; 14():146. PubMed ID: 27183870
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of S100P for pancreatic cancer: a meta-analysis.
Hu H; Zhang Q; Huang C; Shen Y; Chen X; Shi X; Tang W
Tumour Biol; 2014 Oct; 35(10):9479-85. PubMed ID: 25123266
[TBL] [Abstract][Full Text] [Related]
34. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ
Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407
[TBL] [Abstract][Full Text] [Related]
35. Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.
Mu DQ; Peng YS; Xu QJ
World J Gastroenterol; 2004 Feb; 10(4):471-5. PubMed ID: 14966900
[TBL] [Abstract][Full Text] [Related]
36. Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer.
Tascilar M; Caspers E; Sturm PD; Goggins M; Hruban RH; Offerhaus GJ
Ann Oncol; 1999; 10 Suppl 4():107-10. PubMed ID: 10436798
[TBL] [Abstract][Full Text] [Related]
37. A case of small pancreatic cancer diagnosed by serial follow-up studies promptly by a positive K-ras point mutation in pure pancreatic juice.
Ochi K; Hasuoka H; Mizushima T; Matsumura N; Harada H
Am J Gastroenterol; 1998 Aug; 93(8):1366-8. PubMed ID: 9707068
[TBL] [Abstract][Full Text] [Related]
38. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.
Li T; Zheng Y; Sun H; Zhuang R; Liu J; Liu T; Cai W
Med Oncol; 2016 Jul; 33(7):61. PubMed ID: 27225938
[TBL] [Abstract][Full Text] [Related]
39. [The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Zhonghua Nei Ke Za Zhi; 2005 Oct; 44(10):741-4. PubMed ID: 16255879
[TBL] [Abstract][Full Text] [Related]
40. Performance of K-ras mutation analysis plus endoscopic ultrasound-guided fine-needle aspiration for differentiating diagnosis of pancreatic solid mass: a meta-analysis.
Xu Y; Hu D; Zhu Q; Sun Y
Chin Med J (Engl); 2014; 127(18):3296-301. PubMed ID: 25266530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
